Cidara Therapeutics Announces Agreement With Janssen To Develop And Commercialize AVCs For The Prevention And Treatment Of Influenza
Monday, April 5, 2021 8:04 AM EDT
Cidara is developing a new generation of immunotherapeutic antivirals from its Cloudbreak® antiviral platform that couple potent antivirals to a human antibody fragment.